On Friday, stocks trended higher after the U.K. reported preliminary data showing Pfizer (PFE) and BioNTech’s (BNTX) vaccine is effective against the latest COVID-19 strain.
According to the U.K. Health Security Agency (UKHSA), recent studies proved that booster shots were 70% to 75% effective in preventing serious disease from the Omicron mutation.
The report fueled a rally across all S&P 500 Index sectors, with technology stocks leading the pack – a much-needed shift after recent volatility among high-growth stocks.
But, more broadly speaking, this should bode well for a biotech name we’ve been tracking, as a recent drop in value could now make it the perfect time to buy…
The Truth Behind the Global Chip Shortage
Brownstone Research
GM and Toyota factories are shutting down… Mass shortages of electronics… Medical device production nearly halted… But what you probably don’t yet realize–what few so far have figured out… Is what’s really causing it. [Full Story Here…]
One of the larger biotech stocks we’re monitoring is Biogen (BIIB). The company is a multinational company that specializes in developing treatments for neurological diseases.
While Biogen doesn’t operate in the vaccine space, the ongoing pandemic has increased the popularity and interest surrounding the industry. And these tailwinds, combined with the release of several revolutionary drugs, has helped Biogen expand its footprint in recent months.
Even so, shares of Biogen have fallen by more than 42% in the past six months due to controversy over its Alzheimer’s treatment.
Yet, despite this hit in share value, this may not be as much of a concern as headlines may have initially suggested.
Even though many doctors have remained wary of prescribing the U.S. Food and Drug Administration-approved treatment, Aduhelm is still extremely effective at removing beta-amyloid plaque, which contributes to cognitive declines.
And given the fact that it’s the first drug of its kind to receive approval in more than two decades, it means that it will likely remain the only plausible option for many moving forward.
Where to invest $100 right now…
Before you consider buying BIIB, you’ll want to see this.
“Penny Trades” are cheap and explosive…
Warren Buffett grabbed 46 million of them for 1¢ a pop.
Right now, he’s up as much as a rare 4,429% on this trade.
But “Penny Trades” aren’t reserved for billionaires like Buffett.
Thanks to SEC loophole 30.52, you can play them in your brokerage account.
One of these “Penny Trades” shot up 183% in one day…
Penny Trades can pay far MORE than stocks…
Our readers just saw a 19¢ trade shoot up as much as a rare 5,100%…
Here’s the #1 “Penny Trade” for RIGHT NOW.
2,000X Bigger than Bitcoin? Forbes calls THIS the Future
Legacy Research
LIVE ON CAMERA The man who called #1 tech stocks of 2016, 2018, 2019 & 2020 based on return…
Reveals the details of a new tech set to grow:
- 113X bigger than the Internet…
- 600X bigger than 5G…
- 2,000X BIGGER than Bitcoin
“This is the biggest investing moment in 400 years — and just $25 gets you in.”
Brown believes the rollout could be days away… [Full Story…]
